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effectiveness-implementation trial
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David Kalman4,5, Alfredo Axtmayer1, Karishma Kurowski1,2 and Scott E Sherman1,2
Abstract
Background: This paper describes an innovative protocol for a type-II hybrid effectiveness-implementation trial that
is evaluating a smoking cessation telephone care coordination program for Veterans Health Administration (VA)
mental-health clinic patients. As a hybrid trial, the protocol combines implementation science and clinical trial
methods and outcomes that can inform future cessation studies and the implementation of tobacco cessation
programs into routine care. The primary objectives of the trial are (1) to evaluate the process of adapting,
implementing, and sustaining a smoking cessation telephone care coordination program in VA mental health
clinics, (2) to determine the effectiveness of the program in promoting long-term abstinence from smoking among
mental health patients, and (3) to compare the effectiveness of telephone counseling delivered by VA staff with
that delivered by state quitlines.
Methods/design: The care coordination program is being implemented at six VA facilities. VA mental health
providers refer patients to the program via an electronic medical record consult. Program staff call referred
patients to offer enrollment. All patients who enroll receive a self-help booklet, mailed smoking cessation
medications, and proactive multi-call telephone counseling. Participants are randomized to receive this counseling
from VA staff or their state’s quitline. Four primary implementation strategies are being used to optimize program
implementation and sustainability: blended facilitation, provider training, informatics support, and provider
feedback. A three-phase formative evaluation is being conducted to identify barriers to, and facilitators for,
program implementation and sustainability. A mixed-methods approach is being used to collect quantitative
clinical effectiveness data (e.g., self-reported abstinence at six months) and both quantitative and qualitative
implementation data (e.g., provider referral rates, coded interviews with providers). Summative data will be
analyzed using the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) framework.
Discussion: This paper describes the rationale and methods of a trial designed to simultaneously study the clinical
effectiveness and implementation of a telephone smoking cessation program for smokers using VA mental health
clinics. Such hybrid designs are an important methodological design that can shorten the time between the
development of an intervention and its translation into routine clinical care.
Trial registration: ClinicalTrials.gov NCT00724308
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Background
Smoking is responsible for 435,000 deaths per year [1].
Persons with a mental health diagnosis have particularly
high rates of tobacco use and consume over 46% of ciga-
rettes sold in the US [2,3]. Patients with bipolar disor-
der or schizophrenia have the highest smoking rates
(69% and 58-90%, respectively) followed by those with
post-traumatic stress disorder (45-63%) and depression
(31-51%) [3-5]. Nicotine replacement therapy (NRT), bu-
propion, and behavioral interventions are recognized as
effective smoking interventions for patients with and
without mental illness [6-10]. Although in-person behav-
ioral counseling is recognized as the most effective form
of behavioral intervention for smoking, telephone-based
counseling for smoking cessation has greater reach than
in-person counseling and is easily amenable to tailoring
based on patient needs [9,11-13].
Every US state, as well as Washington DC, has a tele-
phone “quitline,” which residents can call to receive self-
help materials, counseling, and, in some states, free or
discounted medications. Unfortunately, telephone coun-
seling has been underutilized among smokers with men-
tal health diagnoses, and there are no published studies
examining its effectiveness specifically in a mental health
sample despite evidence that persons with a mental ill-
ness accept, participate in, and benefit from telephone
counseling programs for other purposes [14-16]. A sin-
gle trial of telephone care coordination for smokers in
primary care clinics that connected patients to their
state quitline for counseling included patients with men-
tal health diagnoses and showed that the program in-
creased long-term abstinence compared with usual care
[17]. However, the number of mental health patients in-
cluded in the trial was too small to make conclusions
about the program’s effectiveness among mental health
patients, and it is unknown whether the program would
function similarly outside the primary care setting. In
addition, it is unclear whether state quitlines can ad-
equately serve smokers with mental illness, who may
need more intensive treatment than the general popula-
tion, especially those quitlines that offer only a single
call or a small number of calls per client. A 2007 survey
of state quitlines revealed that none of the US quitlines
had specialized services for clients with mental illness,
and only 6% had self-help materials tailored for smokers
with mental health conditions [18]. Therefore, mental
health patients may require a larger number of calls and
more tailoring than is currently available from the ma-
jority of state quitlines.
We are conducting a hybrid effectiveness-implementation
trial [19] to simultaneously study the clinical effective-
ness and implementation of a telephone care coordin-
ation program for smokers using Veterans Health
Administration (VA) mental health clinics. Hybrid
effectiveness-implementation study designs are an im-
portant and innovative methodological advance de-
signed to shorten the time between the development of
an intervention and its translation into routine clinical
care. According to Curran et al. [19], there are three pri-
mary types of hybrid designs that lie on a continuum
from clinical effectiveness research to implementation
research. Type I designs focus on studying the clinical
effectiveness of an intervention while observing and
gathering information on the implementation of that
intervention into routine care. Type II designs prioritize
clinical and implementation outcomes equally by con-
currently studying the clinical effectiveness of an inter-
vention and one or more strategies for implementing
that intervention. Type III designs focus on implemen-
tation outcomes by studying one or more implementa-
tion strategies for an intervention while gathering
information about the intervention’s clinical outcomes.
Our trial represents a Type II hybrid design. The trial
will estimate the clinical effectiveness of the care co-
ordination program with VA mental health patients,
compare the effectiveness of quitline counseling to
counseling from VA staff trained to work with smokers
with mental illness, identify important barriers of and
facilitators for implementing the program in VA mental
health treatment settings, and describe key outcomes of
four non-randomized implementation strategies. The
trial has three primary objectives: (1) evaluate the pro-
cess of adapting, implementing, and sustaining a smok-
ing cessation telephone care coordination program in
VA mental health clinics; (2) determine the effectiveness
of the program in promoting long-term abstinence from
smoking among VA mental health clinic patients; and
(3) compare the effectiveness of telephone counseling
delivered by VA staff trained to work with smokers who
have a mental health condition with that delivered by
state quitlines. This paper describes the design and
methodology of the trial.
Methods/design
Overview
Figure 1 provides an overview of the clinical effective-
ness portion of the trial’s design. We are implement-
ing a telephone care coordination program (called the
Telephone Quality Improvement Trial in Mental Health,
or “TeleQuitMH”) at six VA facilities. Mental health pro-
viders refer their smoking patients to the program via
electronic medical record (EMR) consult. The program
calls referred patients to offer enrollment using the pa-
tient’s phone numbers listed in the EMR. Enrolled pa-
tients receive smoking cessation medications and multi-
session, proactive telephone counseling. In a one-to-one
fashion, we randomize patients to receive the proactive
telephone counseling from a VA counselor or their state
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quitline. We survey patients by phone at baseline, two
months, and six months to assess outcomes. We are
using four organizational- or provider-level interventions
to optimize program implementation: blended facilita-
tion, provider training, informatics support, and provider
feedback. We are conducting a three-phase formative
evaluation to identify barriers to and facilitators for pro-
gram implementation.
Study sites
Table 1 describes the structure and target patient popu-
lation of the six participating facilities in New York,
New Jersey, Massachusetts, Vermont, New Hampshire,
and Rhode Island. Each site includes one or more med-
ical centers and multiple outpatient clinics. Like all VA
sites, our participating facilities use a common EMR
that includes clinical reminders for tobacco use screen-
ing and treatment. Usual care for tobacco use at our
sites includes patient access to NRT, Bupropion, and
Varenicline through regular prescribing providers and
in-person smoking cessation clinics offering group
counseling.
Participants
All smokers who see a VA mental health provider at par-
ticipating sites during our intervention period can be re-
ferred to TeleQuitMH. The decision to refer a patient is
based on the provider’s assessment of the appropriate-
ness of referral to a telephone program and the patient’s
agreement to the referral. Eligibility criteria for study
participation include referral from a VA mental health
provider, access to a telephone, and access to a mailing
address (a post-office box is acceptable). An estimated
19,500 smokers use VA mental health services annually
at our six sites. Based on a prior study testing a similar
smoking care coordination program in VA primary care
[17], we anticipate a 25% referral rate and a 50% enroll-
ment rate among the referred, giving a total of about
2400 patients enrolling in the program during our inter-
vention period (1200 of whom will be randomized to VA
counseling and 1200 to quitline counseling).
Clinical intervention: telephone care-coordination
program
The TeleQuitMH care coordination program consists of
the following sequential elements. The program begins
with a provider-level intervention that enables the refer-
ral of patients to tobacco cessation treatment. After the
referral, patient-level treatment intervention begins.
1. Simple EMR referral—The care coordination
program takes advantage of VA usual care that
requires providers to screen patients for tobacco use
and either provide them with counseling or refer
Screening by MH 
provider
19,500 estimated 
MHC smokers at 6 
sites
4,875 anticipated 
referrals (25% 
referral rate)
2,438 enroll (50% 
enrollment rate)
Baseline survey
Mailed self-help 
materials and 
medication 
coordination 
1,219 
randomized to 
VA counseling
1,219 
randomized to 
Quitline 
975 2 month f/u 
completion 
975 2 month f/u 
completion 
853 6 month f/u 
completion 
853 6 month f/u 
completion 
Figure 1 CONSORT flow diagram.
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them to treatment during routine visits. We are not
attempting to standardize the screening process or
counseling given by mental health providers. Our
study introduces a new treatment referral option for
providers—that of referring patients to TeleQuitMH
via a new electronic consult in the EMR. Providers
have the option to confirm the patient’s contact
information and enter free-text information about
their patient in the consult screen, but these
responses are not required. Providers can access the
consult either through the consult menu or through
the tobacco use clinical reminder screens.
2. Proactive outreach—Once our program receives a
referral, we mail the patient a welcome packet that
includes information about the TeleQuitMH
program and study and a brochure containing all
elements of informed consult. One week following
this mailing, program staff call the patient using the
phone number in his or her medical record. Staff
make five attempts over two weeks to reach referred
patients by phone to discuss the smoking cessation
program, offer enrollment, and complete the verbal
informed-consent process. Patients who enroll in
treatment are provided with the next four elements
of the program described below. Patients not
interested in treatment have the opportunity to
enroll in the follow-up surveys only.
3. Medication coordination—All enrolled patients can
receive mailed smoking cessation medications unless
they decline or have contraindications noted by their
referring provider. The method with which the
TeleQuitMH program provides medications varies
by site and is determined by a site Clinical Advisory
Committee formed before site implementation. This
committee consists of key stakeholders from the
departments of Psychiatry, Social Work, Psychology,
Pharmacy, and Smoking Cessation. There are three
prescribing methods from which the Clinical
Advisory Committee can choose:
a. The site can designate one or two prescribers
who will complete all prescriptions for
participants at their site. Based on the success of
the primary care-based projects that used a
designated provider, we recommend this method
to all sites.
b. Referring prescribers prescribe for their patients
at the time of referral to TeleQuitMH. If a patient
was referred by a nonprescriber (e.g., a social
worker), or a referring prescriber did not
prescribe at the time of referral, a TeleQuitMH
research assistant contacts the patient’s regular
psychiatrist or primary care provider to request
medications.
c. A combination of methods 1 and 2 is used.
Referring prescribers can prescribe for their
patients at the time of referral. If a patient was
referred by a nonprescriber or the referring
prescriber did not prescribe at the time of
referral, a TeleQuitMH assistant will contact a
site-designated prescriber to request medications.
4. Self-help materials—All enrolled patients receive a
mailed self-help booklet developed jointly by the
University of Colorado School of Medicine and
Colorado Department of Public Health and
Environment. The two-page booklet provides brief
advice on preparing to quit smoking, setting a quit
date, and preventing relapse. The booklet also
provides corrective information on five common
myths about smoking among persons with a mental
health diagnosis. We tailored this booklet for a VA
mental health population by including brief advice
on linking smoking cessation treatment with regular
mental health care and changing the booklet’s
imagery to include pictures of persons in the
military.
5. Smoking cessation counseling—All enrolled patients
have the opportunity to receive multi-call telephone
counseling. To meet study Aim 3 described above,
we randomize participants to receive this counseling
from a VA counselor or from their state quitline.
VA counseling: For patients randomized to receive
counseling from a VA counselor, they are assigned a
Table 1 Overview of participating facilities
Facility name States
served
Estimated number of MHC
smokers
%
Female
Number of affiliated medical
centers
Number of affiliated
CBOCs
R&D
service
New York Harbor
HCS
NY, NJ 4,500 8 2 6 Y
Bronx VAMC NY, NJ 3,900 6 1 4 Y
New Jersey HCS NJ 5,000 7 2 10 Y
Bedford VAMC MA 2,300 5 1 5 Y
White River Junction
VAMC
VT, NH 1,800 9 1 6 Y
Providence VAMC RI 2,000 6 1 5 Y
HCS = Healthcare System; VAMC = VA Medical Center; CBOC = Community-Based Outpatient Clinic; MHC = Mental Health Clinic.
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VA counselor trained to work with smokers who
have a mental health diagnosis. The counselor
provides structured counseling using a protocol that
we created specifically for this study. The protocol
includes proactive counseling and relapse-sensitive
scheduling. The content is based on motivational
interviewing (MI) and problem solving therapy and
addresses both behavioral and cognitive issues,
including motivation, self-efficacy, difficult
situations, comorbid mental health symptoms,
coping strategies, medication usage, and relapse
prevention. The counseling includes planning
(pre-quit) and follow-up (post-quit) sessions.
Planning sessions: The planning sessions last
approximately 30–60 minutes and help patients
develop an individualized quit plan. Content areas
include smoking and quitting history, motivation,
environmental factors, planning, proper use of
quitting aids, and setting a quit date. Patients receive
one to six planning sessions.
Follow-up sessions: Patients receive follow-up calls at
0, 1, 3, 7, 14, 21, and 30 days after their quit date.
The calls are intended to prevent relapse and to help
those who relapse or slip resume quitting. Follow-up
calls, which last 10–15 minutes, also use a manual
for consistency and fidelity monitoring. Participants
are able to call the program staff in between
scheduled calls if desired.
State quitline counseling: For patients assigned to
state quitline counseling, a research assistant
initiates a “warm transfer” of the patient to their
quitline via a three-way call to start the counseling
process. After the initial three-way call, study
personnel are not involved in any aspect of the
quitline counseling. The quitlines follow their
regular service protocols, which are described in
Table 2.
6. Follow-up—All patients enrolled in the study receive
a call from a research assistant at two and six
months. Patients who are abstinent from smoking
are congratulated, but these assessment calls do not
provide counseling. Patients who have relapsed at
six months are asked if they want to go through the
program again.
Counseling standardization and fidelity
State quitlines have standardized protocols and well-
trained counselors providing counseling. For the VA
counseling arm, the telephone counselors undergo an
initial training consisting of two-to-four hours of MI
training with a clinical psychologist and 20 hours of
training on the study’s clinical protocols. This training
includes role-plays with each other and with the study’s
project director. After the project director has deter-
mined that a counselor has met the role-play training
objectives, the counselor advances to complete a series
of standardized patient (SP) encounters. The SP encoun-
ters involve calling an actor trained to portray a smoker
enrolled in the study and completing planning and
follow-up counseling sessions per study protocol. The
SP encounters are audiotaped and reviewed by a clinical
psychologist and the study’s project director for adher-
ence to protocols and counseling techniques. To ensure
TeleQuitMH counseling standardization and fidelity
after study implementation, the counselors complete
clinical documentation using a template that allows
them to indicate which protocol objectives were covered
during each call and the timing of each call. The study’s
project director completes regular audits of the coun-
selor call documentation to ensure adherence to the
protocol. The counselors also attend weekly group
supervision meetings with a clinical psychologist, during
which time the counselors’ active cases are discussed.
Implementation strategies
We are using a series of implementation strategies at
each site to improve the implementation process and in-
crease the uptake and sustainability of the TeleQuitMH
Table 2 Overview of state quitline services
State Typical number of
counseling sessions
QL-initiated
calls
Client-
initiated calls
Typical length of first
session (min)
Typical length of Follow-up
sessions (min)
Free
medications
MA 6 Y Y 45 20 Patch
NH 4-6 Y Y 45 20 None
NJ 6 Y Y 30 15 None
NY 1 Y Y 20 10 Patch, gum
RI 5 Y Y 45 15 None
VT 2 Y Y 30 20 Patch, gum,
lozenge
CT 5 Y Y 15 10 Patch, gum,
lozenge
QL-initiated = quitline proactively calls clients to deliver counseling; client-Initiated = clients call into the quitline to receive counseling.
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program. We used the Promoting Action on Research
Implementation in Health Services (PARiHS) [20] and
the Predisposing, Reinforcing, and Enabling Constructs
in Educational Diagnosis and Evaluation (PRECEDE)
[21] theoretical frameworks and evidence from the
implementation science literature to guide our choice
of implementation strategies. The PARiHS framework
suggests that the success of implementing an evidence-
based program into practice is determined by three
factors: the evidence supporting the program, the imple-
mentation context, and the process of implementation
facilitation [20]. The PRECEDE framework suggests that
changing provider behavior to use a new intervention is
enhanced by strategies that predispose, enable, and
reinforce behavior change [21]. Based on these frame-
works, we chose four primary implementation strategies
as described below: blended facilitation, provider train-
ing, informatics support, and provider feedback.
Strategy 1: blended facilitation
Based on the PARiHS model, we use a combination of
external and internal facilitation to implement the
TeleQuitMH program. External facilitation is conducted
by the study’s principal investigator (PI) and project dir-
ector, who meet with local stakeholders at each site to
recommend methods for successfully implementing the
care coordination program based on the methods found
to be successful in the primary care-based projects. In-
ternal facilitation is accomplished by each site’s PI, who
is responsible for serving as a local champion for the
project or identifying someone at their site who would
be appropriate to serve as a local champion. In addition,
as described in the medication coordination section
above, we form a Clinical Advisory Committee at each
site to guide local implementation of the TeleQuitMH
program. The committees include local representatives
from the Departments of Psychology, Psychiatry, Social
Work, Smoking Cessation, and Pharmacy. In addition to
the committees’ responsibilities in deciding the medica-
tion coordination structure for their site, the committees
provide guidance on how to inform local providers of
TeleQuitMH, provide input on any foreseeable barriers
to implementation and provider adoption, and decide
how the TeleQuitMH program should work with or
complement any existing smoking cessation programs.
The committees meet regularly before site TeleQuitMH
implementation and as-needed after implementation.
Strategy 2: provider training
Based on the PRECEDE model, to predispose providers
to utilize the TeleQuitMH program, study PIs present
the program to mental health providers at each site dur-
ing regular staff meetings and via email newsletters. The
presentations focus on presenting the evidence behind
the program, including its effectiveness in VA primary
care (including among mental health patients referred
through primary care). The presentations also include a
discussion on how the TeleQuitMH program functions
within the context of each site’s existing mental health
structure and smoking cessation programs.
Strategy 3: informatics support
The PRECEDE model posits that enabling interventions
simplify the implementation of a recommended practice
for providers. To enable the use of TeleQuitMH, we cre-
ate a local electronic consult for the program that allows
providers to refer patients with three-to-four extra clicks
as they complete a regular clinical progress note in the
EMR system. The consult is also attached to the tobacco
clinical reminder and mental health assessment tem-
plates in the EMR system, with which providers are
already familiar. For providers who do not have clinical
privileges to send consults, the study’s project director
also accepts referrals via secure email.
Strategy 4: provider feedback
To reinforce use of the TeleQuitMH program, we use
two strategies. First, we document all patient outreach
and counseling sessions with a clinical progress note that
mental health providers can read in the EMR system.
We also add referring providers as “additional signers”
to key TeleQuitMH progress notes, such as notes
documenting their patients’ enrollment in the program,
their patients’ quit plans, and their patients’ completion
of counseling. This allows providers to see their patients’
progress toward quitting smoking and to view the
TeleQuitMH program as a regular source of care at their
VA facility. Second, we send a regular TeleQuitMH elec-
tronic newsletter from a local opinion leader to all men-
tal health providers at each site. The newsletters include
instructions for referral and detail site-specific progress
with the intervention.
Patient measures
Table 3 provides details on planned patient measures
and timing of administration. Participants complete a
survey at baseline, two months, and six months after
enrollment. Participants complete the surveys over the
telephone with research assistants. We make 10 at-
tempts over one month to reach participants to
complete the surveys. The surveys include a demograph-
ics questionnaire designed by the study team; a smoking
behavior and history questionnaire designed by the study
team; the BASIS-24 scale measuring recent mental
health functioning [22]; an impulsivity scale [23]; a func-
tional health literacy scale [24]; measures of readiness
to quit, motivation, self-efficacy, and attitudes about
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smoking developed by the study team; and satisfaction
with treatment received from the TeleQuitMH program.
Formative/implementation evaluation
The study includes a formative evaluation to help us
modify the care coordination program and implementa-
tion strategies during our study period, to enhance the
interpretation of summative data, and to better inform
future implementation efforts. Table 4 provides details
on formative evaluation activities and measures. We
used the Stetler et al. [25] model to guide the develop-
ment of our formative evaluation methods. This model
identifies four stages of formative evaluation for imple-
mentation research:
1. Developmental phase—Based on our experience
with the primary care-based projects, we anticipate
that it will take six months to implement the
TeleQuitMH program at a site. This time includes
identifying a local champion, obtaining Institutional
Review Board approval, implementing the
TeleQuitMH program’s main components, and
informing providers. During this time we will
conduct mental health provider surveys and
interviews with site stakeholders to measure 1) the
level of organizational readiness of the participating
clinics both in general and specific to the
intervention, 2) perceptions of the evidence
supporting smoking cessation telephone counseling
and smoking cessation medications, 3) perceptions
regarding the feasibility and utility of the planned
intervention, and 4) perceptions of anticipated
barriers or facilitators to the successful
implementation of the intervention. We will also
assess the extent to which each site’s local champion
and Clinical Advisory Committee are interested in,
and actually perform, their project responsibilities,
assess the structure and processes of the site’s state
quitline operations (e.g., hours of operation), and
assess the type and intensity of local smoking
cessation services already available to mental health
patients. We will formulate modifications to the
TeleQuitMH program structure and our provider
outreach/marketing efforts to address findings from
these activities.
2. Implementation/progress-focused phase—For the
purpose of our evaluation, we will combine Stetler
et al.’s implementation and progress-focused phases.
After implementing the TeleQuitMH program at a
site, we assess several patient and provider variables
on a regular basis, including the number of patient
referrals, the percentage and types of providers who
are referring patients, the percent of patients
enrolling and engaging in treatment, and patient
satisfaction with the program. We also conduct a
second provider survey during this phase evaluating
reasons for a provider’s referring or not referring
patients to the program, provider satisfaction with
various aspects of the program, and what, if any,
recommendations providers have for changes to the
program that they feel would improve its
effectiveness. We also assess referral trends in
relation to our provider outreach activities in order
to modify or target future outreach efforts. Last, we
Table 3 Patient measures and assessment schedule
Measures BL 2m 6m
Sociodemographics X
Current and historical smoking behavior X X X
Readiness to quit X X X
Quitting self-efficacy and motivation X X X
Medication assessment: Current use, contraindications to NRT or Bupropion X
Use of prior smoking cessation treatment X X X
Nicotine dependence X X X
Alcohol and substance abuse X X X
Smoking environment: Social support for quitting, household smokers, household smoking rules, employer smoker rules X
Attitudes about smoking X
Mental health symptoms (BASIS-24) X X X
Health literacy X
Impulsivity X
Patient satisfaction with the program X X
Patient assessment of treatment fidelity/counseling content X X
BL = baseline; 2m = two months after enrollment; 6m = six months after enrollment.
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Table 4 Formative evaluation (FE) measures and evaluation schedule
FE Measure/
activity Measure/activity description
Develop-
mental
Impl./
progress
focused
Interpret./
sustainability
focused
Reach/Implementation Analysis
Referral rates Number of patients referred on weekly and monthly basis. X X
Treatment
uptake
Percent of referred patients enrolling in treatment, engaging in treatment, and
completing treatment.
X X
Exposure to
TeleQuitMH
Percent of MH patients for whom tobacco use screening was completed. X
Patient Process Data
Enrollment Rates Rates of enrollment to TeleQuit MH and State quitlines X X
TeleQuitMH
Satisfaction
Self-reported satisfaction with TeleQuitMH structure and treatment (including VA
versus quitline satisfaction) ; assessed 2m and 6m after enrolling
X X
Provider Process Data
Provider Survey
Perceptions of program marketing; how likely they will be to use the program;
barriers to implementation; suggestions for improvement; provider use of the program;
program satisfaction; perceived effectiveness of activities to facilitate implementation;
impact of the program on their patients/client.
X X X
Stakeholder
Interviews
Perceptions of program marketing; how likely they will be to use the program; barriers
to implementation; suggestions for improvement; provider use of the program;
likes/dislikes about the program; impact of the program on their patients/clients.
X X X
Referral rates/
patterns
Percent of providers referring; Number of referrals from each provider; Rates by
provider type
X X
MH Unit Data on Implementation Context
VA Survey of MH
Programs[28]
Clinic’s structure, size, staffing, environment, and resources for meeting MH and
tobacco cessation treatment goals.
X
MH Unit
Performance Data
[29]
Clinic-level performance on VA MH and tobacco performance measures X
Implementation Facilitation - Structure
Site Champion
Presence of a site champion, level of interest in performing site champion duties,
position at the VA, role on the project
X X X
Site Clinical
Advisory Committee
Presence of a site Clinical Advisory Committee, level of interest in performing
Committee duties, Committee members positions at the VA & roles on the project
X X X
Site smoking
cessation services
Presence, types, and structure of site smoking cessation clinic and other local smoking
cessation services
X X
TeleQuitMH
Structure
Structure of the TeleQuitMH program at each site, including design and appearance of
the tobacco cessation clinical reminder, prescribing structure, and referral mechanisms
(e.g., consult design, email referral option)
X X X
State quitline
Structure/Issues
Structure of quitline services; issues/problems identified in connecting TeleQuitMH
patients to quitline services.
X X X
IRB Issues
Time from first submission to receiving IRB approval; type of submission required (full
board review, expedited, exempt); site-specific requirements that may affect TeleQuitMH
implementation and adoption (e.g., detailed consent process)
X X
Implementation Facilitation - Activities
Marketing Efforts Provider outreach efforts, academic detailing, provider feedback. X X
Treatment Fidelity
Extent to which the TeleQuitMH staff are providing the telephone counseling,
medication coordination and warm-transfer to the state quitlines as intended.
X X
MH = mental health.
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continue to assess the impact of each site’s
TeleQuitMH components (e.g., prescribing
structure, referral process) on implementation
fidelity, referral rates and patient uptake, treatment
fidelity by the VA counselors, and the presence and
quality of facilitation provided by the local
champions and Clinical Advisory Committees.
3. Interpretation/sustainability-focused phase—
Following the intervention period at each site, we
collect two additional measures: an organizational
survey of mental health programs, which assesses
each site’s mental Health clinic structure, size,
staffing, environment, and resources [26]; and
mental health unit performance rates on the mental
health treatment and tobacco use clinical reminders
required by the VA [27]. We use these data and the
formative evaluation data collected during the
previous two phases to describe the local
implementation context, to formulate interpretations
of primary outcomes data, and to create
recommendations for future implementation efforts
of the telephone care coordination program.
Summative analyses
We are using the RE-AIM framework to guide summa-
tive data analyses [28]. The RE-AIM framework suggests
that it is crucial for a system-level intervention to con-
sider the following: Reach—the proportion of patients
reached by the intervention; Effectiveness—the effective-
ness of the program at meeting clinical goals; Adoption
—the proportion of providers and patients that used the
intervention; Implementation—the extent the interven-
tion was implemented; and Maintenance—whether the
intervention was maintained over time.
Reach
To assess the reach of the intervention, we will deter-
mine the proportion of mental health patients who were
exposed to the TeleQuitMH program. To do this, we
will first use the EMR system to identify all smokers at
participating facilities who had a mental health visit dur-
ing the intervention period. This group—all smokers
with a mental health visit—will be our denominator. If
the TeleQuitMH-adapted tobacco use clinical reminder
appeared for the patient’s mental health care provider,
we will consider that patient to have been exposed to
TeleQuitMH. Reach will be calculated as the number of
smokers exposed to TeleQuitMH divided by the total
number of smokers with a mental health clinic visit.
Effectiveness
Study Aims 2 and 3 examine the clinical outcomes of
the TeleQuitMH program. For Aim 2 (Determine the ef-
fectiveness of telephone counseling in promoting long-
term abstinence from smoking among mental health pa-
tients) there will be no control group, as these data will
only be collected on patients who enroll in TeleQuitMH.
We will calculate the percentage of participants with
30-day point prevalence abstinence at two and six
months. We will also examine which baseline character-
istics (e.g. age, race/ethnicity, self-efficacy, nicotine ad-
diction, mental health diagnosis, symptom severity) are
associated with abstinence, and we will use multivariable
logistic regression to determine those characteristics that
are independently associated with abstinence. For Aim 3
(Compare the effectiveness of telephone counseling deliv-
ered by VA staff with that delivered by state quitlines)
we will calculate the 30-day point prevalence abstinence
rates at two and six months separately for the two treat-
ment arms and compare these rates using logistic regres-
sion, adjusting for covariables.
We based our power calculation on an ability to detect
a difference in six-month abstinence between our two
randomized groups. We expect the six-month abstin-
ence rate will be 15% in the quitline arm and 20% in the
VA arm. With an anticipated 1200 participants in each
treatment arm, we will have >80% power to detect this
5% difference in abstinence rates between the two arms
at the 0.05 significance level.
Adoption
We will calculate program adoption by providers and
patients across all sites and for each site separately. For
this study, adoption by a provider will be defined as
referring one or more patients to the TeleQuitMH
program; i.e., the provider used our provider-level inter-
vention of adapting the EMR to enable referrals. To cal-
culate the program adoption by providers, we will
generate a list of all mental health providers at each site
using administrative records and a list of all mental
health providers who made at least one referral using
study data. We will then divide the number of providers
who made at least one referral by the total number of
providers. Adoption by a patient will be defined as enrol-
ling in treatment. We will have a list of all patients re-
ferred to TeleQuitMH and the list of patients who enroll
in treatment. We will divide the number of patients who
enroll in treatment by the total number of patients re-
ferred to the program.
Implementation and maintenance
We will assess the program implementation at each site
by examining the activities occurring at each site. There
are eight main implementation activities that need to be
completed to fully implement the TeleQuitMH program
at a site (Table 5). We will score each site on the com-
pletion, fidelity, and intensity of each of these eight ac-
tivities using anchors developed by the study team. We
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will assess program maintenance by examining monthly
referral rates to examine time trends in referrals and
whether patients and providers continue to use the pro-
gram for the full intervention period.
Formative evaluation analyses
Developmental phase
Baseline provider survey and stakeholder interview data
on attitudes toward smoking cessation and perceived
barriers to telephone smoking cessation will be used to
refine the implementation of the intervention. Docu-
mentation of the core structural components of the im-
plementation at each site (e.g., prescribing structure,
pre-existing smoking cessation services, characteristics
of local champion) will be used to ensure the best pos-
sible implementation given site circumstances.
Implementation/progress focuses
Referral rates, treatment uptake and exposure at the
patient level, and responses to TeleQuitMH at the pro-
vider level (collected via surveys, stakeholder inter-
views, and referral rates/patterns), will be continuously
monitored to track program progress and identify sites
that may need additional activities and efforts focused
on facilitating implementation. Information on the
structure of the implementation as it unfolds will be
reviewed at regular staff meetings and linked with ini-
tial patient (enrollment rates, satisfaction) and provider
process data (referral rates and patterns) to determine
next steps for implementation including directed out-
reach/marketing; changes in structure, etc.
Interpretation/sustainability phase
After the intervention period has ended at each site, we
will use the interpretation/sustainability phase of our
formative evaluation to interpret primary outcomes,
using qualitative pattern-matching approaches to explore
how the implementation activities and structure of the
implementation (including treatment fidelity) may help
explain variations in outcomes at the site level. Simi-
larly, data on the implementation context will be ana-
lyzed to determine variation across sites and whether
that variation is associated with both the nature of the
implementation and the outcomes achieved. Formative
evaluation data will be analyzed longitudinally to deter-
mine if changes in implementation are associated with
changes in process variables (e.g., reach, uptake). In
terms of sustainability, analyses will focus on identifying
the site and implementation features and characteristics
that facilitated and hampered effectiveness. Finally, de-
scriptions of the degree to which core elements of
TeleQuitMH were integrated into systems of care at
each site will be used to characterize the sustainability
of TeleQuitMH and to identify the local conditions
which facilitate replication and dissemination.
Economic evaluation
It is not within the scope of this project to conduct a
cost-effectiveness analysis. For this project, we will assess
the costs involved with the TeleQuitMH program, in-
cluding staff costs (salary and fringe benefits), cost of
smoking cessation medications, and VA overhead. We
will use data from the VA’s Decision Support System for
the costs of provider time and smoking cessation medi-
cations. We will calculate the cost associated with coun-
seling delivery using study administrative records for the
VA counseling arm and quitline program estimates for
the quitline arm. We will use VA rental space agree-
ments at our primary site to estimate the cost of VA
overhead associated with the program.
Discussion
It can take 17 years for new clinical interventions to
make their way through the efficacy-effectiveness-imple-
mentation research pipeline and become usual clinical
care that improves patient outcomes in routine practice
settings [29]. Hybrid effectiveness-implementation study
designs offer the potential to greatly shorten this transla-
tion time [19]. This study utilizes an innovative hybrid
design to concurrently study the clinical outcomes and
implementation into routine care of a smoking cessation
telephone care coordination program for mental health
patients in six VA facilities. The study will study the clin-
ical effectiveness of the care coordination program and
compare the effectivness of two models for connecting
mental health patients to telephone smoking cessation
counseling (a tailored VA-staffed program versus a
warm-transfer of patients to their state quitline), while
producing important data about the acceptability and
feasibility of telephone-based smoking cessation treat-
ment among mental health providers and patients. For-
mative evaluation data collected during study start-up
and regularly throughout the intervention period will
Table 5 Major TeleQuitMH implementation activities at
each site
1. Designation of a local champion for the program
2. Creation of a site Clinical Advisory Committee
3. Creation of site prescribing structure
4. Modification of EMR system to enable referrals and local
documentation of treatment delivery
5. Permission and process to make warm-transfers of patients to the
state quitline
6. Program marketing to providers
7. Provider referrals
8. Delivery of smoking cessation counseling and smoking cessation
medications to enrolled patients.
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help future tobacco control efforts in mental health
treatment settings by identifying barriers to and facilita-
tors of successful treatment program implementation.
The study will have several limitations. First, we will
rely on self-reported abstience, which may produce over-
estimates of short- and long-term quit rates among par-
ticipants. Second, there is considerable variability in
services provided by the quitlines, and we will not have
sufficient power to conduct Aim 3 analyses separately
for each state. Third, we randomize at the patient-level
and will not be able to determine the effectiveness of
our implementation strategies. However, researchers can
use the qualitative and nonrandomized implementation
outcomes data collected during the trial to design future
group-randomized studies evaluating the effectiveness of
different stratagies for implementing tobacco cessation
treatment programs in mental health clinics. Lastly, we
will not have data on the number or duration of coun-
seling sessions provided to participants connected to the
quitlines for counseling, so we will be unable to account
for treatment intensity in our Aim 3 analyses.
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